DK1196174T3 - Diætmæssigt calcium, som et tilskud til D-vitamin-forbindelsesbehandling af multipel sclerose - Google Patents

Diætmæssigt calcium, som et tilskud til D-vitamin-forbindelsesbehandling af multipel sclerose

Info

Publication number
DK1196174T3
DK1196174T3 DK00941671T DK00941671T DK1196174T3 DK 1196174 T3 DK1196174 T3 DK 1196174T3 DK 00941671 T DK00941671 T DK 00941671T DK 00941671 T DK00941671 T DK 00941671T DK 1196174 T3 DK1196174 T3 DK 1196174T3
Authority
DK
Denmark
Prior art keywords
multiple sclerosis
vitamin
supplement
compound treatment
dietary calcium
Prior art date
Application number
DK00941671T
Other languages
Danish (da)
English (en)
Inventor
Hector F Deluca
Margherite T Cantorna
Jean Humpal-Winter
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of DK1196174T3 publication Critical patent/DK1196174T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00941671T 1999-07-08 2000-06-23 Diætmæssigt calcium, som et tilskud til D-vitamin-forbindelsesbehandling af multipel sclerose DK1196174T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/349,528 US6479474B2 (en) 1999-07-08 1999-07-08 Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
PCT/US2000/017323 WO2001003704A1 (fr) 1999-07-08 2000-06-23 Calcium dietetique comme suplement des traitements de la sclerose en plaques a base de composes de vitamine d

Publications (1)

Publication Number Publication Date
DK1196174T3 true DK1196174T3 (da) 2007-12-27

Family

ID=23372774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00941671T DK1196174T3 (da) 1999-07-08 2000-06-23 Diætmæssigt calcium, som et tilskud til D-vitamin-forbindelsesbehandling af multipel sclerose

Country Status (8)

Country Link
US (3) US6479474B2 (fr)
EP (1) EP1196174B1 (fr)
JP (1) JP2003504337A (fr)
AT (1) ATE369864T1 (fr)
AU (1) AU5634500A (fr)
DE (1) DE60035996T2 (fr)
DK (1) DK1196174T3 (fr)
WO (1) WO2001003704A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060189532A1 (en) * 2005-02-14 2006-08-24 Deluca Hector F Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
US7566696B2 (en) * 2002-09-05 2009-07-28 Wisconsin Alumni Research Foundation Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
WO2004076468A1 (fr) 2003-02-25 2004-09-10 Kobe Tennenbutsu Kagaku Kabushiki Kaisha Nouveaux intermediaires pour la synthese de derives de la vitamine d
CA2518079A1 (fr) * 2003-03-04 2004-10-28 Teva Pharmaceutical Industries, Ltd. Traitement combine a base d'acetate de glatiramer et d'alphacalcidol, destine au traitement de la sclerose en plaques
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
EP1656157B1 (fr) * 2003-08-20 2011-12-21 Wisconsin Alumni Research Foundation Composes de la 2-methylene-19-nor-vitamine d2
US20050080109A1 (en) * 2003-10-09 2005-04-14 Papas Andreas M. Gamma-tocopherol and gamma-tocotrienol therapy for multiple sclerosis
US20060194185A1 (en) * 2005-02-10 2006-08-31 David Goldberg Information request system and method
WO2006086608A1 (fr) * 2005-02-11 2006-08-17 Wisconsin Alumni Research Foundation 2-methylene-19-nor-(20s-24epi)-1$g(a),25-dihydroxyvitamine-d2
US7563783B2 (en) * 2005-02-11 2009-07-21 Wisconsin Alumni Research Foundation 2-methylene-19-nor-(20S-24S)-1α,25-dihydroxyvitamin-D2
EP1931390B1 (fr) * 2005-10-05 2012-07-25 Bayhill Therapeutics, Inc. Compositions et methodes de traitement de maladies auto-immunes
CA2655357A1 (fr) * 2006-06-13 2007-12-21 Bayhill Therapeutics, Inc. Therapie a base de polynucleotides
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279826A (en) 1980-09-22 1981-07-21 Wisconsin Alumni Research Foundation 23,25-Dihydroxyvitamin D3
US4307025A (en) 1981-02-17 1981-12-22 Wisconsin Alumni Research Foundation 1α, 25-dihydroxy-2β-fluorovitamin D3
US4448721A (en) 1982-09-20 1984-05-15 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 compounds and process for preparing same
US5036061A (en) 1983-05-09 1991-07-30 Deluca Hector F Process for the preparation of 1 alpha,25-dihydroxylated vitamin D2 and related compounds
US4500460A (en) 1983-08-18 1985-02-19 Wisconsin Alumni Research Foundation 23,23-Difluoro-25-hydroxy-vitamin D3 and process for preparing same
US4502991A (en) 1983-08-18 1985-03-05 Wisconsin Alumni Research Foundation 23,23-Difluoro-1α,25-dihydroxy-vitamin D3
US4769181A (en) 1983-11-07 1988-09-06 Wisconsin Alumni Research Foundation 1,25-dihydroxyvitamin D2 compounds
US4505906A (en) 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US4588528A (en) 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4594192A (en) 1985-03-20 1986-06-10 Wisconsin Alumni Research Foundation 2α-fluorovitamin D3
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US4619920A (en) 1985-09-16 1986-10-28 Wisconsin Alumni Research Foundation 26,26,26,27,27-pentafluoro-1α-hydroxy-27-methoxyvitamin D3
JPS63104926A (ja) 1986-10-21 1988-05-10 Teijin Ltd 老年性痴呆症治療又は予防剤
US4973584A (en) 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
CA1333616C (fr) 1989-03-09 1994-12-20 Hector F. Deluca Composes de type 19-nor-vitamine d
US5030772A (en) 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
US5260290A (en) 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
JP2845342B2 (ja) 1990-04-28 1999-01-13 大正製薬株式会社 ビタミンｄ▲下３▼誘導体含有固形製剤組成物
HUT66379A (en) 1991-05-28 1994-11-28 Procter & Gamble Calcium, trace mineral, vitamin d and drug therapy combinations
US5260199A (en) 1991-07-30 1993-11-09 Wisconsin Alumni Research Foundation Method of producing 1,25-dihydroxyvitamin D3 receptor protein
DE69214617T2 (de) 1991-12-26 1997-05-28 Wisconsin Alumni Res Found 26,27-Dimethylen-1-Alpha, 25-Dihydroxyvitamin-D2 und 26,27-Dihydroxyvitamin-D2 und Verfahren zu ihrer Herstellung
AU666529B2 (en) 1992-04-24 1996-02-15 Wisconsin Alumni Research Foundation Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
TW272187B (fr) 1992-05-20 1996-03-11 Hoffmann La Roche
ES2091515T3 (es) 1992-05-20 1996-11-01 Hoffmann La Roche Analogos fluorados de la vitamina d3.
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
US5371249A (en) 1993-05-11 1994-12-06 Wisconsin Alumni Research Foundation Iodo vitamin D3 compounds and method for preparing same
US5380720A (en) 1993-05-11 1995-01-10 Wisconsin Alumni Research Foundation Iodo vitamin D3 compounds and method for preparing same
WO1995001960A1 (fr) 1993-07-09 1995-01-19 Laboratoire Theramex S.A. Nouveaux analogues structuraux de la vitamine d
US5373004A (en) 1993-11-24 1994-12-13 Wisconsin Alumni Research Foundation 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
US5716946A (en) 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
DE19710054A1 (de) 1997-03-12 1998-09-17 Merck Patent Gmbh Pharmazeutische Zubereitung
AU732331B2 (en) 1997-04-28 2001-04-12 F. Hoffmann-La Roche Ag Vitamin D3 analogs with bis C-20 side chains
WO1998051678A1 (fr) 1997-05-16 1998-11-19 Women & Infants Hospital COMPOSES DE VITAMINE D3 A ETHER CYCLIQUE ET COMPOSES DE 1α(OH)3-EPI-VITAMINE D3, ET UTILISATION DESDITS COMPOSES
US6673782B2 (en) 1999-04-29 2004-01-06 Wisconsin Alumni Research Foundation Treatment of systemic lupus erythematosis

Also Published As

Publication number Publication date
WO2001003704A1 (fr) 2001-01-18
US20030022873A1 (en) 2003-01-30
US20030207847A1 (en) 2003-11-06
JP2003504337A (ja) 2003-02-04
DE60035996D1 (de) 2007-09-27
US20020016313A1 (en) 2002-02-07
EP1196174B1 (fr) 2007-08-15
AU5634500A (en) 2001-01-30
ATE369864T1 (de) 2007-09-15
EP1196174A1 (fr) 2002-04-17
US6479474B2 (en) 2002-11-12
DE60035996T2 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
DK1494692T3 (da) Topiske, farmaceutiske sammensætninger, der omfatter proanthocyanidiner, glycyrrhetinsyre og telmestein til behandlingen af dermatitis
DK1196174T3 (da) Diætmæssigt calcium, som et tilskud til D-vitamin-forbindelsesbehandling af multipel sclerose
DE602004010493D1 (de) Kaugummi in der form von mehrschichttabletten
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
WO2005041924A3 (fr) Administration de levodopa et de carbidopa
TR200100610T2 (tr) Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
BR0210139A (pt) Composições farmacêuticas
WO2004041269A3 (fr) Nouvel emploi pour composition pharmaceutique
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
DE60325265D1 (de) Antioxidative zusammensetzungen
PT1560826E (pt) Compostos piridopirimidinona, seus processos de preparacao e composicoes farmaceuticas que os contem
IS2575B (is) Ný samverkandi samsetning sem felur í sér róflúmílast og formóteról
MEP34308A (en) Oral formulations of cladribine
DK1242067T3 (da) Calciumformiat som et kosttilskud
IS7899A (is) Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról
DE69819519D1 (de) Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
ME00547B (me) Upotreba inhibitora il-18 kod poremećaja hipersenzitinosti (preosjetljivosti)
AR046245A1 (es) Sales de calcio de rabeprazol
IT1265647B1 (it) Composizione farmaceutiche topiche per le allergie respiratorie
NO20044700L (no) Ny assoiasjon av et antitrombotisk middel og aspirin
DE60112578D1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
DK1490049T3 (da) Citalopram til behandling af forhöjet blodtryk